Aspire Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Sell |
478
-156
| -25% | -$122K | 0.1% | 76 |
|
|
2025
Q1 | $524K | Buy |
634
+1
| +0.2% | +$827 | 0.16% | 56 |
|
|
2024
Q4 | $489K | Buy |
633
+160
| +34% | +$124K | 0.14% | 53 |
|
|
2024
Q3 | $419K | Buy |
473
+30
| +7% | +$26.6K | 0.12% | 54 |
|
|
2024
Q2 | $402K | Buy |
443
+12
| +3% | +$10.9K | 0.13% | 48 |
|
|
2024
Q1 | $336K | Buy |
431
+28
| +7% | +$21.8K | 0.11% | 57 |
|
|
2023
Q4 | $235K | Hold |
403
| – | – | 0.1% | 60 |
|
|
2023
Q3 | $216K | Buy |
+403
| New | +$216K | 0.1% | 62 |
|